OPRX - OptimizeRx's (OPRX) CEO William Febbo on Q3 2021 Results - Earnings Call Transcript

OptimizeRx Corporation (OPRX) Q3 2021 Earnings Conference Call November 9, 2021 4:30 PM ET Company Participants William Febbo – Chief Executive Officer Ed Stelmakh – Chief Financial Officer Stephen Silvestro – Chief Commercial Officer Andrew D’Silva – Senior Vice President of Corporate Finance Conference Call Participants Jared Haase – William Blair Sean Dodge – RBC Capital Markets Eric Martinuzzi – Lake Street Marc Wiesenberger – B. Riley Securities Presentation Operator Good afternoon, and thank you for joining OptimizeRx Corporation’s Third Quarter Fiscal 2021 Earnings Discussion. With us today is the Chief Executive Officer of OptimizeRx, William Febbo. He is joined by Company Chief Financial Officer, Ed Stelmakh; President and Chief Strategy Officer, Miriam Paramore; Chief Commercial Officer, Stephen Silvestro; Executive Vice President of Finance and Accounting, Doug Baker; General Counsel and Chief Compliance Officer, Marion Odence-Ford; and Senior Vice President of Corporate Finance, Andrew D’Silva. Before we conclude earnings call,

For further details see:

OptimizeRx's (OPRX) CEO William Febbo on Q3 2021 Results - Earnings Call Transcript